Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Elastic Therapeutic Tape Market 2018, Forecast to 2023

US$ 4,880.00

... on the Elastic Therapeutic Tape in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, ...

July 2018 149 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Electric Wheelchair (Powered Wheelchairs) Market 2018, Forecast to 2023

US$ 4,880.00

... the Electric Wheelchair (Powered Wheelchairs) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This ... regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, ...

July 2018 128 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Energy Based Device in Hyperhidros Market 2018, Forecast to 2023

US$ 4,880.00

... the Energy Based Device in Hyperhidros in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, ...

July 2018 129 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Head Lice Infestation Drug Market 2018, Forecast to 2023

US$ 4,880.00

... report focuses on the Head Lice Infestation Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes ...

July 2018 147 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Horseradish Peroxidase (HRP) Market 2018, Forecast to 2023

US$ 4,880.00

... on the Horseradish Peroxidase (HRP) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, ...

July 2018 137 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Molecular Microbiology Market 2018, Forecast to 2023

US$ 4,880.00

... focuses on the Molecular Microbiology in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, ...

July 2018 137 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Perphenazine Market 2018, Forecast to 2023

US$ 4,880.00

... of the Report: This report focuses on the Perphenazine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes ...

July 2018 131 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Phytases Market 2018, Forecast to 2023

US$ 4,880.00

... This report focuses on the Phytases in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, ...

July 2018 137 pages

Global Respiratory Drug Market Research and Forecast 2018-2023

US$ 3,600.00

... : Global Respiratory drug market Research and Analysis, By Drug Global Respiratory drug market Research and Analysis, By Drug Class Global Respiratory drug market Research and Analysis, By Route of Administration Global Respiratory drug market Research and Analysis, By End User Global Respiratory drug market ...

July 2018 -

Indian Pharmaceutical Contract Manufacturing Market Research and Forecast 2018-2023

US$ 1,200.00

... . India’s generics accounting for 20% of global exports (in volume terms). Major factors contributing to the growth of the Indian pharmaceutical contract manufacturing market include increasing investments in the Indian pharmaceutical sector ...

July 2018 -

Global Influenza Vaccines Market, Persons Vaccinated, Brand Analysis, Size, Share, Growth, Trends, Major Deals - Forecast to 2024

US$ 1,800.00

... Inc. for development of a universal influenza vaccine. This is the 4th edition report on influenza vaccines market by iGATE Research. The report titled “Global Influenza Vaccines Market, Persons Vaccinated, Brand Analysis, Size, Share ...

July 2018 224 pages

Hyperlipidemia Drugs Market Analysis Report by Drug Class (Statins, PCSK9 Inhibitors, Bile Acid Sequestrants, Cholesterol Absorption Inhibitors, Fibric Acid Derivatives, Combination), and Segment Forecasts, 2016 - 2022

US$ 5,950.00

The global hyperlipidemia drugs market size is expected reach USD 22.6 billion by 2022, according to a new report by ... (CVD) due to persistent hypercholesterolemia, are stoking the growth of the market. Hyperlipidemia is the most common type of dyslipidemia and is generally caused by abnormally ...

July 2018 98 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Clinical Mass Spectrometry Market 2018, Forecast to 2023

US$ 4,880.00

... : This report focuses on the Clinical Mass Spectrometry in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes ...

July 2018 129 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Patient Infotainment Terminals Market 2018, Forecast to 2023

US$ 4,880.00

... on the Patient Infotainment Terminals in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, ...

July 2018 130 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Tumor Ablation Market 2018, Forecast to 2023

US$ 4,880.00

... report focuses on the Tumor Ablation in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... , regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, ...

July 2018 129 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Zika Virus Market 2018, Forecast to 2023

US$ 4,880.00

... report focuses on the Zika Virus in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... , regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, ...

July 2018 134 pages

Global Patient Infotainment Terminals Market by Manufacturers, Regions, Type and Application, Forecast to 2023

US$ 3,480.00

... display the global Patient Infotainment Terminals market. Chapter 1, to describe Patient Infotainment Terminals Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Patient Infotainment Terminals, with ...

July 2018 137 pages

Investigation Report on Chinese Imatinib Market, 2018-2022

US$ 2,200.00

... environment of Imatinib in China Forecast on market size of Imatinib in China Market share of major Imatinib manufacturers in China Retail prices of Imatinib in China Development of generic Imatinib in China India-made Imatinib smuggled to China Prospects of Chinese Imatinib market, 2018 ...

July 2018 30 pages

Investigation Report on Chinese Latanoprost Market, 2018-2022

US$ 2,200.00

... -operative medications, and thus a high demand for Latanoprost in China. Topics Covered: Development environment of Latanoprost in China Sales of Latanoprost in China Major Latanoprost manufacturers in China Retail prices of Latanoprost in China Prospects of Chinese Latanoprost market

July 2018 30 pages

Investigation Report on Chinese Sorafenib Market, 2018-2022

US$ 2,200.00

... that China-made Sorafenib will appear on the market after 2022. Topics Covered: Sales of Sorafenib in China Prices of Sorafenib in China Sales of Sorafenib in China by region Sales of India-made Sorafenib in China Prospects of Chinese Sorafenib ...

July 2018 30 pages

Investigation Report on Chinese Thymosin ?1 Market, 2018-2022

US$ 2,200.00

... China, with its sales value increasing from less than CNY 7 million in 2015 to more than CNY 1.2 billion in 2017. The Chinese Thymosin ... Size of Chinese Thymosin α1 market Competition pattern of the Chinese Thymosin α1 market Prices in the Chinese Thymosin α1 market Prospects of the Chinese Thymosin α1 market

July 2018 30 pages

Adult Vaccine Market, Global Analysis By Disease (Influenza, Cervical Cancer, Zoster, MMR , Pneumonia, Meningitis, Hepatitis, Tap , Varicella & Travel & Miscellaneous Vaccine) & Companies

US$ 1,690.00

... report titled “Adult Vaccine Market, Global Analysis By Disease [Influenza, Cervical Cancer, Zoster (Shingles), MMR (Measles, Mumps, and Rubella), Pneumonia, Meningitis, Hepatitis, Tap (Diphtheria, Tetanus, Pertussis), Varicella and Travel & Miscellaneous Vaccine], Companies (GlaxoSmithKline ...

July 2018 -

Pediatric Vaccine Market, Global Forecast Infants Vaccinated, Vaccines Administered, Immunization, By Disease (Influenza, MMR, Pneumonia, Meningitis, Hepatitis, Tap, Hib, Polio, etc) & Companies

US$ 1,690.00

... Pediatric Vaccine Market, Global Forecast Infants Vaccinated, Vaccines Administered, Immunization, By Disease [Influenza, MMR (Measles, Mumps, and Rubella), Pneumonia, Meningitis, Hepatitis, Tap (Diphtheria, Tetanus, Pertussis), Haemophilus influenzae type B (Hib), Polio, Rotavirus, Varicella, and Combination ...

July 2018 -

Atypical Hemolytic Uremic Syndrome (Nondiarrhea - Associated Hemolytic Uremic Syndrome) - Pipeline Review, H2 2018

US$ 2,000.00

... Atypical Hemolytic Uremic Syndrome (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Atypical Hemolytic Uremic Syndrome (Nondiarrhea - Associated Hemolytic Uremic Syndrome) and features dormant and discontinued projects. The guide covers therapeutics under ...

July 2018 91 pages

Macrophage Stimulating Protein Receptor (CDw136 or Protein Tyrosine Kinase 8 or p185 Ron or CD136 or MST1R or EC 2.7.10.1) - Pipeline Review, H2 2018

US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Macrophage Stimulating Protein Receptor (CDw136 or Protein Tyrosine Kinase 8 or p185 Ron or CD136 or MST1R or EC 2.7.10.1) development landscape Develop and design ...

July 2018 54 pages

Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) - Pipeline Review, H2 2018

US$ 3,500.00

... Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

July 2018 44 pages

Nuclear Receptor ROR Gamma (Nuclear Receptor RZR Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR Related Orphan Receptor C or Retinoid Related Orphan Receptor Gamma or RORC) - Pipeline Review, H2 2018

US$ 3,500.00

... being developed by Companies/Universities. It also reviews key players involved in Nuclear Receptor ROR Gamma (Nuclear Receptor RZR Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR Related Orphan Receptor C or Retinoid Related Orphan Receptor Gamma or RORC) targeted therapeutics development with ...

July 2018 106 pages

Peroxisome Proliferator Activated Receptor Delta (NUCI or Nuclear Hormone Receptor 1 or Nuclear Receptor Subfamily 1 Group C Member 2 or Peroxisome Proliferator Activated Receptor Beta or NR1C2 or PPARD) - Pipeline Review, H2 2018

US$ 3,500.00

... also reviews key players involved in Peroxisome Proliferator Activated Receptor Delta (NUCI or Nuclear Hormone Receptor 1 or Nuclear Receptor Subfamily 1 Group C Member 2 or Peroxisome Proliferator Activated Receptor Beta or NR1C2 or PPARD) targeted therapeutics development with respective active and dormant ...

July 2018 83 pages

Tumor Necrosis Factor Receptor Superfamily Member 5 (B Cell Surface Antigen CD40 or Bp50 or CDw40 or CD40L Receptor or TNFRSF5 or CD40) - Pipeline Review, H2 2018

US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Tumor Necrosis Factor Receptor Superfamily Member 5 (B Cell Surface Antigen CD40 or Bp50 or CDw40 or CD40L Receptor or TNFRSF5 or CD40) development landscape Develop and ...

July 2018 87 pages

Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) - Pipeline Review, H2 2018

US$ 3,500.00

... Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

July 2018 82 pages

Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Pipeline Review, H2 2018

US$ 3,500.00

... Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

July 2018 71 pages

Mucin 1 (Breast Carcinoma Associated Antigen DF3 or Episialin or H23AG or Krebs Von Den Lungen 6 or PEMT or Peanut Reactive Urinary Mucin or Polymorphic Epithelial Mucin or Tumor Associated Epithelial Membrane Antigen or Tumor Associated Mucin or CD227 or MUC1) - Pipeline Review, H2 2018

US$ 3,500.00

... reviews Mucin 1 (Breast Carcinoma Associated Antigen DF3 or Episialin or H23AG or Krebs Von Den Lungen 6 or PEMT or Peanut Reactive Urinary Mucin or Polymorphic Epithelial Mucin or Tumor Associated Epithelial Membrane Antigen or Tumor Associated Mucin or CD227 or MUC1) targeted therapeutics under development ...

July 2018 89 pages

Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Pipeline Review, H2 2018

US$ 3,500.00

... Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

July 2018 73 pages

Glutamate Receptor Ionotropic NMDA 2B (Glutamate [NMDA] Receptor Subunit Epsilon 2 or N Methyl D Aspartate Receptor Subtype 2B or N Methyl D Aspartate Receptor Subunit 3 or GRIN2B) - Pipeline Review, H2 2018

US$ 3,500.00

... by Companies/Universities. It also reviews key players involved in Glutamate Receptor Ionotropic NMDA 2B (Glutamate [NMDA] Receptor Subunit Epsilon 2 or N Methyl D Aspartate Receptor Subtype 2B or N Methyl D Aspartate Receptor Subunit 3 or GRIN2B) targeted therapeutics development with respective active and ...

July 2018 57 pages

Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 (Bcl 2 Like Protein 3 or Bcl 2 Related Protein EAT/Mcl1 or BCL2L3 or MCL1) - Pipeline Review, H2 2018

US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 (Bcl 2 Like Protein 3 or Bcl 2 Related Protein EAT/Mcl1 or BCL2L3 or MCL1) development landscape Develop and ...

July 2018 69 pages

Tumor Necrosis Factor Receptor Superfamily Member 1A (Tumor Necrosis Factor Receptor 1 or Tumor Necrosis Factor Receptor Type I or p55 or p60 or CD120a or TNFRSF1A) - Pipeline Review, H2 2018

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Tumor Necrosis Factor Receptor Superfamily Member 1A (Tumor Necrosis Factor Receptor 1 or Tumor Necrosis Factor Receptor Type I or p55 or p60 or CD120a or TNFRSF1A) development ...

July 2018 42 pages

Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) - Pipeline Review, H2 2018

US$ 3,500.00

... Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

July 2018 101 pages

Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) - Pipeline Review, H2 2018

US$ 3,500.00

... Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

July 2018 68 pages

Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) - Pipeline Review, H2 2018

US$ 3,500.00

... Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

July 2018 66 pages

Caspase 8 (Apoptotic Cysteine Protease or Apoptotic Protease Mch 5 or CAP4 or FADD Homologous ICE/Ced-3 Like Protease or FADD Like ICE or ICE Like Apoptotic Protease 5 or MORT1 Associated Ced 3 Homolog or CASP8 or EC 3.4.22.61) - Pipeline Review, H2 2018

US$ 3,500.00

... reviews key players involved in Caspase 8 (Apoptotic Cysteine Protease or Apoptotic Protease Mch 5 or CAP4 or FADD Homologous ICE/Ced-3 Like Protease or FADD Like ICE or ICE Like Apoptotic Protease 5 or MORT1 Associated Ced 3 Homolog or CASP8 or EC 3.4.22.61) targeted therapeutics development with respective ...

July 2018 71 pages

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H2 2018

US$ 3,500.00

... Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

July 2018 51 pages

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Pipeline Review, H2 2018

US$ 3,500.00

... Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

July 2018 41 pages

5' Nucleotidase (Ecto 5' Nucleotidase or CD73 or NT5E or EC 3.1.3.5) - Pipeline Review, H2 2018

US$ 3,500.00

... and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding 5' Nucleotidase (Ecto 5' Nucleotidase or CD73 or NT5E or EC 3.1.3.5) development landscape Develop and design in-licensing and ...

July 2018 55 pages

78 kda Glucose Regulated Protein (Endoplasmic Reticulum Lumenal Ca(2+) Binding Protein Grp78 or Heat Shock 70 kDa Protein 5 or Immunoglobulin Heavy Chain Binding Protein or HSPA5) - Pipeline Review, H2 2018

US$ 3,500.00

... ) and molecule type. It also reviews key players involved in 78 kda Glucose Regulated Protein (Endoplasmic Reticulum Lumenal Ca(2+) Binding Protein Grp78 or Heat Shock 70 kDa Protein 5 or Immunoglobulin Heavy Chain Binding Protein or HSPA5) targeted therapeutics development with respective active and dormant ...

July 2018 42 pages

Cathepsin K (Cathepsin O or Cathepsin O2 or Cathepsin X or CTSK or EC 3.4.22.38) - Pipeline Review, H2 2018

US$ 3,500.00

... and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Cathepsin K (Cathepsin O or Cathepsin O2 or Cathepsin X or CTSK or EC 3.4.22.38) development landscape Develop and design in-licensing and ...

July 2018 41 pages

G Protein Coupled Bile Acid Receptor 1 (G Protein Coupled Receptor GPCR19 or Membrane Type Receptor For Bile Acids or hBG37 or GPR131 or GPBAR1) - Pipeline Review, H2 2018

US$ 3,500.00

... identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding G Protein Coupled Bile Acid Receptor 1 (G Protein Coupled Receptor GPCR19 or Membrane Type Receptor For Bile Acids or hBG37 or GPR131 or GPBAR1) development landscape Develop ...

July 2018 32 pages

Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) - Pipeline Review, H2 2018

US$ 3,500.00

... Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

July 2018 44 pages

Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) - Pipeline Review, H2 2018

US$ 3,500.00

... Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

July 2018 51 pages

Leptin Receptor (HuB219 or OB Receptor or CD295 or LEPR) - Pipeline Review, H2 2018

US$ 3,500.00

... Leptin Receptor (HuB219 or OB Receptor or CD295 or LEPR) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

July 2018 51 pages

Mitogen Activated Protein Kinase 8 (c Jun N Terminal Kinase 1 or JNK 46 or Stress Activated Protein Kinase JNK1 or Stress Activated Protein Kinase 1c or MAPK8 or EC 2.7.11.24) - Pipeline Review, H2 2018

US$ 3,500.00

... players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Mitogen Activated Protein Kinase 8 (c Jun N Terminal Kinase 1 or JNK 46 or Stress Activated Protein Kinase JNK1 or Stress Activated Protein Kinase 1c or MAPK8 or EC 2.7.11.24) development ...

July 2018 44 pages

Filters

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1